The biomedical research institutes of Tarragona, Girona and Lleida receive funding to maintain their joint project of internationalization of research

MORE INFO

Cristina Aluja

The biomedical research institutes of Tarragona, Girona and Lleida receive funding to maintain their joint project of internationalization of research

  • The IISPV, IDIBGI and IRBLleida will receive more than 361,000 euros over 3 years from the Beyond GO_HERO project
  • It is a commitment by the three research centres to offer solutions to existing health challenges
  • The project gives continuity to a previous initiative that allowed the international funds raised by the three CERCA institutions to increase by more than 40%

The Pere Virgili Health Research Institute (IISPV), the Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI) and the Biomedical Research Institute of Lleida Fundació Dr. Pifarré (IRBLleida) have received a total of 361,474 euros in the call for the Strategic Health Research and Innovation Plan (PERIS) 2022-2027 of the Department of Health, in order to maintain their joint internationalization initiative, the project Beyond GO_HERO.

The Beyond GO_HERO (Health European Research Offices) project, coordinated by the IDIBGI, began in 2023 and is scheduled to end on December 31, 2025. The proposal is presented as the consolidation of the international project units of the three centers , all of them members of the CERCA system of the Generalitat de Catalunya. The initiative seeks to train units with skills and knowledge to take the step towards increased leadership in proposals and in the number of proposals requested at international level. Another objective of the project is to train the research staff of the institutes in different key areas for the preparation of highly competitive quality projects.

This new project is the continuation of the GO_HERO project, which allowed the professionalization of the international project units of the three centers and their technical staff. The sum of efforts gave tangible results in all areas, such as an increase of more than 40% in the collection of international funds, such as the 25% increase in international proposals presented, the 5% increase in the success rate in calls for proposals, the diversification of funding sources, the increase in the number of international projects and more participation by the research groups of the three institutions.

The impact of the Beyond GO_HERO project will be significant as it will maintain the impetus for the three institutes to consolidate their presence in European and international research. This increase will contribute to strengthening Catalonia’s position within the European biomedical and clinical map, in addition to the possible inclusion in the European agenda of the particular health needs of the territory’s citizens.

This initiative is part of the existing collaboration agreement between the three institutes. Apart from having similar indicators of scientific production, the three regions share health challenges in providing coverage to a geographically dispersed population, older than that of the metropolitan areas and with less investment. This situation makes collaboration vitally important, not only between the institutes but with other European entities, to be able to offer solutions to existing challenges in health, both regionally and internationally.

For Dr. Marga Nadal, director of the IDIBGI, “the GO_HERO project proved to have an impact on the participating institutions in terms of the number of proposals presented and funded. Now the GO_HERO project seeks excellence, professionalization and the leap towards the leadership of international proposals”.

According to Dr. Joan Vendrell, director of the IISPV, “this continuity of the joint project will position the participating centers in a prominent place on the biomedical map of Catalonia with a remarkable international projection and very valuable for our territory”.

For Dr. Diego Arango, director of the IRBLleida, “thanks to the project we will boost the attraction of international funding through participation and leadership in competitive consortia and we will strengthen institutional relations”.

About the IISPV

The Pere Virgili Health Research Institute (IISPV) is a research institute created in 2005, to manage biomedical and health research in the Camp de Tarragona and Terres de l’Ebre. The IISPV is participated by: ICS Camp de Tarragona with the University Hospital of Tarragona Joan XXIII, ICS Terres de l’Ebre with the Hospital Verge de la Cinta, the University Hospital Sant Joan de Reus, the Pere Mata Group and Rovira i Virgili University.

About the IDIBGI

The Biomedical Research Institute of Girona Dr. Josep Trueta (IDIBGI) is a CERCA center dedicated to translational, clinical and epidemiological research aimed at improving people’s health and care. With more than 400 researchers and researchers, which includes health professionals and basic researchers, it is organized into 22 research groups in five areas of health: Cardiovascular and Respiratory, Metabolism and Inflammation, Neurosciences, Oncohematology and Mental Health. The IDIBGI is linked to the main healthcare institutions in Girona, such as the Trueta Hospital in Girona and the Santa Caterina Hospital in Salt.

About the IRBLleida

The Biomedical Research Institute of Lleida Fundació Dr. Pifarré (IRBLleida) was created with the aim of creating synergies between basic, clinical and epidemiological research, making biomedical research a key driver for improving current clinical practice. The IRBLleida covers a chain of translational research, from basic research, aimed at understanding the physiological and pathological mechanisms of the human body, to research that studies the behavior of diseases in large population groups.

More information

Unitat de Comunicació IISPV
A/e: comunicacio@iispv.cat
977 75 93 94 (Hospital Sant Joan de Reus) | 977 29 58 00 (Hospital Joan XXIII de Tarragona)
Unitat de Comunicació IDIBGI A/e: comunicacio@idibgi.org
872 987 087  Ext. 15
Unitat de Comunicació IRBLleida
A/e: comunicacio@irblleida.cat 973 702 479